Initial clinical experience with oral manganese (CMC-001) for liver MR imaging

European Radiology

Volumn 17, Issue 1, 2007, Pages 273-278

  Thomsen, Henrik S ^a   Barentsz, Jelle O ^b   Burcharth, Flemming ^a   Chabanova, Elizaveta ^a   Dekker, Helena M ^b   Moesgaard, Flemming ^a   Moller, Jakob M ^a   Leth Espensen, Per ^a   Logager, Vibeke ^a   Takahashi, Satoru ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hepatobiliary imaging; Livermetastases; MRI; Oralmanganese

Indexed keywords

CMC 001; CONTRAST MEDIUM; MANGANESE DERIVATIVE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEPATOBILIARY DISEASE; HUMAN; KLATSKIN TUMOR; LIVER HEMANGIOMA; LIVER INJURY; LIVER METASTASIS; LIVER PARENCHYMA; MALE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PRIORITY JOURNAL;

ADULT; AGED; CONTRAST MEDIA; FEMALE; HUMANS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 33846062294     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0336-9     Document Type: Article

References (16)

1. Bellin M-F (2006) Safety of MR liver specific agents. In: Thomsen HS (ed) Safety issues and ESUR guidelines. Heidelberg, Springer Verlag pp 121-128
2. Bartolozzi C, Donati F, Cioni D, Crocetti L, Lencioni R (2000) MnDPDP-enhanced MRI vs. dual phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 10:1697-1702
3. Thomsen HS, Loegager V, Noergaard H, Chabanova E, Moller JM, Sonne J (2004) Oral manganese for liver imaging at three different field strengths. Acad Radiol 2004 11:630-636
4. Chabanova E, Thomsen HS, Loegager V et al (2004) Effect of new manganese contrast agent on tissue intensities: Comparison of 0.23 T, 0.6T and 1.5 T MRI. A part of a phase I trial. MAGMA 17:28-35
5. Semelka RC, Helmberger TKG (2001) Contrast agents for MR imaging of the liver. Radiology 218:27-38
6. Thomsen HS, Svendsen O, Klastrup S (2004) Increased manganese concentration in the liver after oral intake. Acad Radiol 11:38-44
7. Mena I (1981) Manganese. In: Bronner F, Coburn JW (eds.) Disorders on mineral metabolism. Academic Press, New York pp 233-270
8. Underwood EJ (1971). Manganese. In: Underwood EJ (ed). Trace elements in human and animal nutrition. Academic Press, New York pp 177-207
9. Keen CL, Lönnerdal B, Hurley LS (1984) Manganese. In: Frieden J (ed) Biochemistry of the essential ultra-trace elements. Plenum Press, New York pp 89-132
10. Korc M (1988) Manganese homeostasis in humans and its role in disease states. In: Korc M (ed) Essential and toxic trace elements in human health and disease. Alan R. Liss, New York pp 253-273
11. Marti-Bonmati L, Fog AF, Op de Beeck B et al (2003) Safety and efficacy of mangafodipir trisodium in patients with liver lesions and cirrhosis. Eur Radiol 13:1685-1692
12. Fore H, Morton RA (1952) Manganese in rabbit tissue. Biochem J 51:600
13. Tipton IH, Cook MJ (1963) Trace elements in human tissue. II. Adult subjects from the United States. Health Phys 9:103
14. Sahani DV, Kalva SP, Fischman AJ et al (2005) Detection of metastases from andenocarcinoma of the colon and pancreas: Comparison of mangadipir trisodium-enhanced liver MRI and whole-body FDG PET. Am J Roentgenol 185:239-246
15. Fayad LM, Kamel IR, Mitchell DG, Bluemke DA (2005) Functional MR cholangiography: Diagnosis of functional abnormalities of the gall bladder and biliary tree. Am J Roentgenol 184:1563-1571
16. Hottat N, Winant C, Metens T, Bourgeois N, Devière J, Matos C (2005) MR cholangiography with manganese dipyridoxyl diphosphate in the evaluation of biliary-enteric anastomoses: Preliminary experience. Am J Roentgenol 184:1556-1562